“We believe in a future where biomanufacturing is seamless, scalable, and accessible to all, driving innovation and improving lives.”

Dr. Jason Murphy is a renowned expert with over 25 years of trailblazing experience at industry giants like Moderna, Eli Lilly, and Merck. As a pivotal figure in the development and manufacturing of Moderna’s COVID-19 vaccine, Dr. Murphy led a dynamic, cross-functional team, ensuring the rapid and safe production of this and other groundbreaking therapies.

At Eli Lilly, he spearheaded the Lilly Fermentation Development Technical Center. His leadership extended to the Biotech and Fermented Products Network, where he was instrumental in supporting operations that contributed to nearly half of Elanco’s revenue.

During his 14-year tenure at Merck, Dr. Murphy was a key player in the process development and commercialization of vaccines and biologics.

Dr. Murphy holds a B.S. in Chemical Engineering from the University of California, Berkeley, and both an M.S. and Ph.D. in Chemical Engineering from the University of Houston.